Reduced Appetite to the Point of Food Aversion Some users report a near total disinterest in food, which can lead to inadequate protein intake, dehydration, or electrolyte imbalance if not managed carefully
However, there were no significant differences in HbA1c reductions between any of the cotadutide dose groups and the liraglutide (1.8 mg) group
In this guide, well explain how each peptide works, compare their benefits and potential side effects, and help you determine which option may be the better fit for your needs
however, individual responses vary and monitoring is important
Candidate patient groups who may benefit most include: Women with thinned or scarred endometrium post-surgery propensity for local repair and angiogenesis
Most people on tirzepatide lose 20 to 22% of their body weight, while semaglutide users lose around 14 to 15%